Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

Comment by BioTeckon Mar 24, 2021 3:04am
145 Views
Post# 32864378

RE:RE:RE:RE:RE:RE:RE:RE:Wow! What a news release

RE:RE:RE:RE:RE:RE:RE:RE:Wow! What a news releaseRed, I obviously know what the company is up to. My point is regarding promo. You know as well as I do but you can pretend all you want. Dominic blows. He couldn't even setup a conference call with enough lines, released something during blackout and I could keep going but anyone invested in the company already knows including you. You can go around fluffing management all you want but they suck at running a business. This stock will never be 20 dollars like the herd thinks. I'm just waiting for some heavy volume and some more percentage so I can sell and move heavy into my next play. Not saying you won't do alright if you are patient but I'm in the business of making returns when the market conditions are right. I'm sure I'll do just fine in this stock but time is of the essence and these muppets are dragging their feet. It'll be interesting to see what happens to this stock when me and some other longs that hold a mountain of shares decide to exit. I just hope we don't all decide to pull the plug at the same time. Over 300mil shares out, don't forget.
Redbaron2211 wrote: Met/Bio you can only move so fast with signing deals implanting patients ext/  Ball may be in Pharmas court, Witkowski could be implanting patients while in the meantime Sernova team is being productive.  Dominic has been excellent at keeping the pace and I like his style. He's a major asset to this team.    We have more money now so we will see some things move faster especially on hemo and thyroid front.   My point is if you have a disruptive tech promo doesn't matter cheap or expensive it's beyond the point.  Spending money on traditional advertisements is fruitless in my opinion and in this day in age the successful companies like tesla spend money on the R and D to make a product so good it will speak for itself and your starting to see this with Sernova.

Regarding the "big update" I feel Philip is aiming more at institutional investment now.  Were stable over 1$, tsxv50, just did a large institutional raise. Institutional investment is what will gain us traction with our current listings.  If we list on Nasdaq it will be a different world of retail promo likely led by institutional investment but these are the steps to that.   We have milestones to look forward to with thyroid in April more updates from Witkowski in June all while wild cards of licensing deals could come anytime.  


<< Previous
Bullboard Posts
Next >>